Venkataraman Balasubramanian
Examiner (ID: 17374, Phone: (571)272-0662 , Office: P/1624 )
Most Active Art Unit | 1624 |
Art Unit(s) | 1624, 1611 |
Total Applications | 2999 |
Issued Applications | 2017 |
Pending Applications | 254 |
Abandoned Applications | 728 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 10399414
[patent_doc_number] => 20150284423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => '3-(4\'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE'
[patent_app_type] => utility
[patent_app_number] => 14/443778
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6033
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443778
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/443778 | 3-(4′-substituted)-benzyl-ether derivatives of pregnenolone | Nov 26, 2013 | Issued |
Array
(
[id] => 10399414
[patent_doc_number] => 20150284423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => '3-(4\'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE'
[patent_app_type] => utility
[patent_app_number] => 14/443778
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6033
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443778
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/443778 | 3-(4′-substituted)-benzyl-ether derivatives of pregnenolone | Nov 26, 2013 | Issued |
Array
(
[id] => 10399414
[patent_doc_number] => 20150284423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => '3-(4\'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE'
[patent_app_type] => utility
[patent_app_number] => 14/443778
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6033
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443778
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/443778 | 3-(4′-substituted)-benzyl-ether derivatives of pregnenolone | Nov 26, 2013 | Issued |
Array
(
[id] => 10399414
[patent_doc_number] => 20150284423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => '3-(4\'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE'
[patent_app_type] => utility
[patent_app_number] => 14/443778
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6033
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443778
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/443778 | 3-(4'-substituted)-benzyl-ether derivatives of pregnenolone | Nov 26, 2013 | Issued |
Array
(
[id] => 10399414
[patent_doc_number] => 20150284423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => '3-(4\'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE'
[patent_app_type] => utility
[patent_app_number] => 14/443778
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6033
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443778
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/443778 | 3-(4′-substituted)-benzyl-ether derivatives of pregnenolone | Nov 26, 2013 | Issued |
Array
(
[id] => 10399414
[patent_doc_number] => 20150284423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => '3-(4\'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE'
[patent_app_type] => utility
[patent_app_number] => 14/443778
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6033
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443778
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/443778 | 3-(4'-substituted)-benzyl-ether derivatives of pregnenolone | Nov 26, 2013 | Issued |
Array
(
[id] => 10399414
[patent_doc_number] => 20150284423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => '3-(4\'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE'
[patent_app_type] => utility
[patent_app_number] => 14/443778
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6033
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443778
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/443778 | 3-(4′-substituted)-benzyl-ether derivatives of pregnenolone | Nov 26, 2013 | Issued |
Array
(
[id] => 9384578
[patent_doc_number] => 20140088060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'METHOD OF TREATING DISORDER RELATED TO HIGH CHOLESTERAL CONCENTRATION'
[patent_app_type] => utility
[patent_app_number] => 14/092178
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12150
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14092178
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/092178 | METHOD OF TREATING DISORDER RELATED TO HIGH CHOLESTERAL CONCENTRATION | Nov 26, 2013 | Abandoned |
Array
(
[id] => 10399414
[patent_doc_number] => 20150284423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => '3-(4\'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE'
[patent_app_type] => utility
[patent_app_number] => 14/443778
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6033
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443778
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/443778 | 3-(4'-substituted)-benzyl-ether derivatives of pregnenolone | Nov 26, 2013 | Issued |
Array
(
[id] => 10399414
[patent_doc_number] => 20150284423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => '3-(4\'-SUBSTITUTED)-BENZYL-ETHER DERIVATIVES OF PREGNENOLONE'
[patent_app_type] => utility
[patent_app_number] => 14/443778
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6033
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443778
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/443778 | 3-(4′-substituted)-benzyl-ether derivatives of pregnenolone | Nov 26, 2013 | Issued |
Array
(
[id] => 11184709
[patent_doc_number] => 09416102
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-16
[patent_title] => '(22E)-2-methylene-22-dehydro-1α,24,25-trihydroxy-19-nor-vitamin D3 analogs'
[patent_app_type] => utility
[patent_app_number] => 14/084281
[patent_app_country] => US
[patent_app_date] => 2013-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8401
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14084281
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/084281 | (22E)-2-methylene-22-dehydro-1α,24,25-trihydroxy-19-nor-vitamin D3 analogs | Nov 18, 2013 | Issued |
Array
(
[id] => 9757334
[patent_doc_number] => 20140288036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => 'NOVEL C-17-HETEROARYL STEROIDAL CYP17 INHIBITORS/ANTIANDROGENS, IN VITRO BIOLOGICAL ACTIVITIES, PHARMACOKINETICS AND ANTITUMOR ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/081910
[patent_app_country] => US
[patent_app_date] => 2013-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13972
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14081910
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/081910 | NOVEL C-17-HETEROARYL STEROIDAL CYP17 INHIBITORS/ANTIANDROGENS, IN VITRO BIOLOGICAL ACTIVITIES, PHARMACOKINETICS AND ANTITUMOR ACTIVITY | Nov 14, 2013 | Abandoned |
Array
(
[id] => 10451994
[patent_doc_number] => 20150337006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'PREPARATIONS OF HYDROPHOBIC THERAPEUTIC AGENTS, METHODS OF MANUFACTURE AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/759133
[patent_app_country] => US
[patent_app_date] => 2013-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 50
[patent_no_of_words] => 53067
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14759133
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/759133 | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof | Nov 12, 2013 | Issued |
Array
(
[id] => 11090577
[patent_doc_number] => 20160287545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'COMPOUND PARTICULARLY FOR TREATING DEPRESSION AND ANXIETY'
[patent_app_type] => utility
[patent_app_number] => 14/442654
[patent_app_country] => US
[patent_app_date] => 2013-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18605
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14442654
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/442654 | COMPOUND PARTICULARLY FOR TREATING DEPRESSION AND ANXIETY | Nov 12, 2013 | Abandoned |
Array
(
[id] => 10580940
[patent_doc_number] => 09303058
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-05
[patent_title] => 'Betulonic and betulinic acid derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/075093
[patent_app_country] => US
[patent_app_date] => 2013-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 17353
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075093
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/075093 | Betulonic and betulinic acid derivatives | Nov 7, 2013 | Issued |
Array
(
[id] => 9561941
[patent_doc_number] => 20140179654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'ENZYMATIC PROCESS FOR OBTAINING 17 ALPHA- MONOESTERS OF CORTEXOLONE AND/OR ITS 9,11- DEHYDRODERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/073928
[patent_app_country] => US
[patent_app_date] => 2013-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 4504
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14073928
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/073928 | Enzymatic process for obtaining 17α-monoesters of cortexolone and/or its 9,11-dehydroderivatives | Nov 6, 2013 | Issued |
Array
(
[id] => 10234375
[patent_doc_number] => 20150119367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-30
[patent_title] => 'Phosphate Esters of Bimatoprost and the Prostamides'
[patent_app_type] => utility
[patent_app_number] => 14/065698
[patent_app_country] => US
[patent_app_date] => 2013-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45509
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14065698
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/065698 | Phosphate Esters of Bimatoprost and the Prostamides | Oct 28, 2013 | Abandoned |
Array
(
[id] => 10649259
[patent_doc_number] => 09365493
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-14
[patent_title] => 'Synthesis of tetracyclines and analogues thereof'
[patent_app_type] => utility
[patent_app_number] => 14/063868
[patent_app_country] => US
[patent_app_date] => 2013-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 28
[patent_no_of_words] => 54481
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14063868
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/063868 | Synthesis of tetracyclines and analogues thereof | Oct 24, 2013 | Issued |
Array
(
[id] => 11596841
[patent_doc_number] => 09643993
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-09
[patent_title] => 'Crystalline polymorphic form of ulipristal acetate'
[patent_app_type] => utility
[patent_app_number] => 14/431351
[patent_app_country] => US
[patent_app_date] => 2013-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 9457
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431351
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/431351 | Crystalline polymorphic form of ulipristal acetate | Sep 25, 2013 | Issued |
Array
(
[id] => 11596842
[patent_doc_number] => 09643994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-09
[patent_title] => 'Crystalline polymorphic form of ulipristal acetate'
[patent_app_type] => utility
[patent_app_number] => 14/431357
[patent_app_country] => US
[patent_app_date] => 2013-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 10082
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431357
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/431357 | Crystalline polymorphic form of ulipristal acetate | Sep 25, 2013 | Issued |